Novartis | NOVARTIND | NSE - Pharmaceuticals
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..
Upgrade Membership to see 10 year accurate financial statements.
Chart | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Cash and cash equiva... |
| 8,157 | 7,751 | 878 | 5,819 | 4,989 |
Short-term investment |
| 0 | 10 | 5,227 | 0 | 9 |
Accounts receivables |
| 452 | 439 | 456 | 376 | 387 |
Inventories |
| 875 | 566 | 605 | 587 | 480 |
Deferred income taxes |
| 0 | 0 | 0 | 0 | 0 |
Other current assets |
| 257 | 766 | 899 | 1,349 | 1,376 |
Total current assets |
| 9,742 | 9,532 | 8,065 | 8,131 | 7,240 |
Gross property plant... |
| 57 | 46 | 150 | 120 | 89 |
Accumulated Depriciat... |
| 0 | 0 | 0 | 0 | 0 |
Net property, plant and Eq... |
| 57 | 46 | 150 | 120 | 89 |
Work in Progress |
| 0.1 | 0 | 0 | 0 | 0 |
Miscellaneous Investment |
| 17 | 60 | 0 | 47 | 50 |
Deferred income taxes |
| 1,422 | 1,149 | 214 | 1,524 | 1,740 |
Intangible assets |
| 0 | 0 | 0 | 0 | 0 |
Goodwill |
| 0 | 0 | 0 | 0 | 0 |
Other long-term assets |
| 262 | 319 | 1,396 | 954 | 904 |
Total non-current assets |
| 1,758 | 1,573 | 1,760 | 2,645 | 2,783 |
Total assets |
| 11,499 | 11,105 | 9,824 | 10,776 | 10,023 |
Short-term debt |
| 0 | 0 | 0 | 0 | 0 |
Accounts Payable... |
| 736 | 2,443 | 914 | 726 | 552 |
Provisions |
| 112 | 131 | 0 | 185 | 219 |
Taxes Payable |
| 77 | 67 | 87 | 87 | 122 |
Deferred Revenues |
| 0 | 0 | 0 | 0 | 0 |
Capital Leases |
| 0 | 0 | 0 | 118 | 127 |
Other current liabilities |
| 935 | 655 | 849 | 1,212 | 569 |
Total current liabilities |
| 1,859 | 3,296 | 1,850 | 2,328 | 1,590 |
Long-term debt |
| 23 | 0 | 0 | 0 | 0 |
Investments Liabilities |
| 0 | 0 | 0 | 0 | 0 |
Deferred tax liabilities |
| 0 | 0 | 0 | 0 | 0 |
Provisions |
| 0 | 0 | 350 | 659 | 808 |
Capital Leases |
| 0 | 0 | 0 | 565 | 498 |
Other longterm liabilities |
| 421 | 473 | 32 | 17 | 16 |
Total non-current liabilities |
| 444 | 473 | 382 | 1,241 | 1,322 |
Total liabilities |
| 2,303 | 3,769 | 2,233 | 3,569 | 2,911 |
Share Capital |
| 141 | 123 | 123 | 123 | 123 |
Share premium |
| 0 | 0 | 36 | 0 | 0 |
Retained earnings |
| 9,056 | 7,213 | 7,475 | 7,084 | 6,989 |
Accumulated other equity |
| 0 | 0 | -43 | 0 | 0 |
Preferred Stock |
| 0 | 0 | 0 | 0 | 0 |
Minority Interest |
| 0 | 0 | 0 | 0 | 0 |
Total Equity |
| 9,196 | 7,336 | 7,592 | 7,207 | 7,112 |
Total Liabilities and Equity |
| 11,499 | 11,105 | 9,824 | 10,776 | 10,023 |
Cash per Share |
| Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |
Cash, Current Inv Per share |
| Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |